We are accelerating our impact and working with patients, doctors, scientists, government and industry to improve genomic testing, and help researchers access the health data and ... necessary to ...
EXL’s third quarter results were met with a negative market reaction despite outperforming Wall Street’s revenue and non-GAAP ...